Option Investor
Newsletter

INITIAL MARCH OPTIONWRITER RECOMMENDATIONS

HAVING TROUBLE PRINTING?
Printer friendly version

The following are the initial put writes for our
MARCH RECOMMENDATION LIST

Initial MARCH RECOMMENDATIONS:

We are starting the MARCH expiration series with four (4) put writes


We are recommending put writes in the following issues:

MYGN - Myriad Genetics, Inc.
a biopharmaceutical company, engages in the development and marketing of therapeutic and molecular diagnostic products. Its lead drug candidate is Flurizan, a therapeutic drug for the treatment of Alzheimer's disease, which completed a Phase II human clinical trial in patients with mild to moderate Alzheimer's disease. Flurizan is also in a Phase IIb human clinical trial for the treatment of patients with premetastatic prostate cancer

GGB - Gerdau S.A.
engages in the production and distribution of crude steel and related long rolled products, drawn products, and long specialty products. The company produces steel based on the minimill concept, whereby steel is produced in electric arc furnaces from scrap and pig iron. Gerdau also produces steel from iron ore.

AMR - AMR Corporation (AMR)
through its principal subsidiary, American Airlines, Inc., operates as a scheduled passenger airline. The company operates scheduled air freight carriers, as well as provides freight and mail services to shippers. AMR, through its AMR Eagle Holding Corporation subsidiary, also owns two regional airlines, which do business as the American Eagle carriers. It also contracts with three independently owned regional airlines that do business as the American Connection.

PEIX - Pacific Ethanol, Inc.,
through its wholly owned subsidiary, Kinergy Marketing, LLC, markets ethanol in the western United States. The company also offers transportation, storage, and delivery of ethanol through third-party service providers. It sells ethanol primarily in California, Nevada, Arizona, and Oregon, as well as throughout the western United States.

We are recommending the following specific put writes:

MYGN $24.51
SELL MYGN MAR SYM: GSQ-OX
Target Price $30.00 22.5 Put
Potential Profit(10 x = $300.00
Initial Margin $5,202 10 (contracts)
Return on Investment 5.77%
Cost Basis in Stock = $22.20
Days to Expiration = 36
Stock goes on Watch List Price at: $24.00
STOP EXIT STRATEGY
Close option position if Stock CLOSES less than $22.50


GGB $20.28
SELL GGB MAR SYM: GGB-OW
Target Price $25.00 17.5 Put
Potential Profit(10 x = $250.00
Initial Margin $4,306 10 (contracts)
Return on Investment 5.81%
Cost Basis in Stock = $17.25
Days to Expiration = 36
Stock goes on Watch List Price at: $19.00
STOP EXIT STRATEGY
Close option position if Stock CLOSES less than $17.50

AMR $24.96
SELL AMR MAR SYM: AMR-OD
Target Price $35.00 20 Put
Potential Profit(10 x = $350.00

Initial Margin $5,342 10 (contracts)
Return on Investment 6.55%
Cost Basis in Stock = $19.65
Days to Expiration = 36
Stock goes on Watch List Price at: $21.50
STOP EXIT STRATEGY
Close option position if Stock CLOSES less than $20.00

PEIX $18.00
SELL PEIX MAR SYM: PFQ-OC
Target Price $50.00 15 Put
Potential Profit(10 x = $500.00

Initial Margin $4,100 10 (contracts)
Return on Investment 12.20%
Cost Basis in Stock = $14.50
Days to Expiration = 36
Stock goes on Watch List Price at: $16.50
STOP EXIT STRATEGY
Close option position if Stock CLOSES less than $15.00


We will be adding more recommendations later this week after FEBRUARY options
have expired.


Option Writers Newsletter Archives